drugset / Trial / NCT00208091

Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia

NCT00208091

NaSingle-groupOpen-labelTreatment

Summary

This study uses a computerized method of musical instrument digital interface (MIDI) quantification of performance before and after treatment with botulinum toxin type B (Myobloc ®, Solstice Neurosciences). Myobloc is a purified and diluted form of botulinum toxin used medically to relax unwanted muscle spasms and movements. The aim of the study is to determine the feasibility of quantifying change in performance following treatment.

Timeline

Start
2003-04
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum Toxin Type B Unknown 500 iu Intramuscular

Indications